IL6 and neoplasm: Inflammatory biomarkers (such as TNF-α, IL-1, IL-6, vascular endothelial growth factor, matrix metalloproteinases) may lead to metastases, tumor progression and inefficiency of adjuvant chemotherapy [19,20,21].